Navigation Links
Study defines effective microbicide design for HIV/AIDS prevention

Duke University biomedical engineers have developed a computer tool they say could lead to improvements in topical microbicides being developed for women to use to prevent infection by the virus that causes AIDS.

Providing women with improved microbicides is a pressing challenge because women now account for a growing number of new infections worldwide, the researchers said.

By applying fundamentals of physics and chemistry, the researchers developed a computer model that can predict the effectiveness of various microbicidal recipes in destroying human immunodeficiency virus (HIV) before it reaches vulnerable body tissues.

Using the tool, the researchers have determined that a thin, long-lasting coating of microbicide delivered to susceptible tissues in a woman's vagina can significantly reduce the spread of HIV.

The researchers reported their findings in the September 2006 Biophysical Journal.

The findings emphasize a critical role for the "delivery vehicle," the various polymer gels or creams that carry the active antimicrobial ingredients, in determining the success or failure of microbicides, according to the researchers. Yet, they add, most scientists have concentrated on improving the antimicrobial compounds themselves, rather than their delivery.

"There is a huge push to produce microbicides that would have any effectiveness at all in reducing the spread of HIV, particularly in places like Africa and Southeast Asia where the disease is rampant," said David Katz, a professor of biomedical engineering at Duke's Pratt School of Engineering and one of the computer tool's developers. "We are developing methodologies to make the next round of microbicides even better."

"Existing microbicides are excellent in terms of their ability to inactivate HIV," added Anthony Geonnotti, the study's lead investigator, who is a Ph.D. candidate in Katz's laboratory. "Improvements to future generations of microbicides
'"/>

Source:Duke University


Page: 1 2 3

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works

Post Your Comments:
(Date:11/25/2009)...tomach, may be used to boost resistance to, or slo...hool of Medicine researchers report in a study pub...cience . , Parkinson,s disease is caused by a de...idbrain known as the substantia nigra, which is re...tion of dopamine in late-stage Parkinson,s causes ...
(Date:11/25/2009)...e officers and ambulance workers faced a terrifyin... They battled to save people from the collapsing T...and evacuated as many people as they could in an a...d making their jobs even harder was the problem of... relatives jammed mobile networks with calls and t...
(Date:11/25/2009)... is the linchpin of the environment, where atmosph..., many students see soil as "just dirt" a place t...ators are challenged with the task of helping stud...nce of soil in the environment. , A collaborati...ers at University of Nebraska-Lincoln, Oregon Stat...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2New nanostructure technology provides advances in eyeglass solar energy performance 14160 1New nanostructure technology provides advances in eyeglass solar energy performance 14160 2New blood tests promise simple cost effective diagnosis of gastrointestinal cancers 9987 1New blood tests promise simple cost effective diagnosis of gastrointestinal cancers 9987 2New blood tests promise simple cost effective diagnosis of gastrointestinal cancers 9987 3New blood tests promise simple cost effective diagnosis of gastrointestinal cancers 9987 4deCODE Discovers Four New Risk Factors for Prostate Cancer 5020 1deCODE Discovers Four New Risk Factors for Prostate Cancer 5020 2deCODE Discovers Four New Risk Factors for Prostate Cancer 5020 3deCODE Discovers Four New Risk Factors for Prostate Cancer 5020 4
..., Sustainable farming that employs shade trees ma...cipitation extremes that climate changes are expec...in the October issue of BioScience . The article,...rmeer, of the University of Michigan, focuses on c... be applicable to other economically important cro...
...Financial Services Provider Deploys Biometric Acce...eed for PINs or ID Cards, WALL, N.J., Sept. 30 B...I), a leader in wireless public safety,solutions a...d today that,Parente Randolph ("Parente"), a leadi...O-key,s biometric identity solution to secure thei...
..., WASHINGTON DC The Federation of American Scien...ck TM the first biologically accurate immunology ... ESA Foundation (ESAF). This bold and fun game is ...tack . , "We expect to release the next version o...egman, project manager for the FAS Learning Techno...
Other Biology News:Parente Randolph Secures Access to New Corporate Headquarters With BIO-key(R) Biometric Identification 2Parente Randolph Secures Access to New Corporate Headquarters With BIO-key(R) Biometric Identification 3Entertainment Software Association Foundation awards grant to FAS for immune attack 2
(Date:11/25/2009)...ia/--SinovacBiotechLtd.(SVA),aleadingdeveloperand...ointventure(JV)agreementtoestablishSinovac(Dalian)...lresearch,develop,produce,andcommercializehuman-us...erienceindevelopingandcommercializingworld-classva...ufacturingfacilitiesand,establishedoperatinginfras...
(Date:11/24/2009)... to also Visit Detroit , ..., French Ambassador for International Investment, ...y, , , , ,What: Ambassador Appia is available to ...tiatives adopted by France to further develop the ...ation and development., , ,When: Available for Int...
(Date:11/24/2009)...irstCall/--Sigma-AldrichCorporation(Nasdaq: SIAL )...December1stat1:45PMGMTinLondon,7:45AMUS/CST.Intere...ternetavailableat http://inve s tor.sig m a ...cessthisfile. ,, AboutSigma-Aldrich: Sigma-A...y.Itschemicalandbiochemicalproductsandkitsareusedi...
(Date:11/24/2009)...sia/--ShanghaiBiolaxyannouncedthe,ChineseStateFood...igationalnewdrugapplication(IND)foritsoralinsulinp...eatdiabetes.ThisIND,approvalallowsBiolaxytoinitiat...sordercharacteristicofhighbloodglucoseandpoor,meta...remicro-and,macro-vasculardiseases,lossofvision,ki...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
...d of,Directors of Shire plc (LSE: SHP, NASDAQ: SHP...cal company, announces today that David Mott will,...mediate effect. Mr Mott is Chief Executive Office...ppointed to in 2000. He joined MedImmune in 1992 a... in finance, strategic planning,business developme...
...utical Inc. (Nasdaq and SWX: BMRN) announced today...cer of BioMarin, will present a,company update at ...nce in,New York City on Wednesday, November 7, 200... a live audio webcast of the presentation,via the ...www.BMRN.com . A,replay of the presentation will b...
...ulletin Board: MODG) today announced that senior m... & Renshaw 9th Annual Healthcare Conference on,Wed...ence will be held at,the New York Palace Hotel in ...esident Shai Novik will attend.,Management will pr...evelopments. The presentation will be webcast liv...
Other Biology Technology:David Mott Appointed Non Executive Director at Shire 2David Mott Appointed Non Executive Director at Shire 3Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2
Anti-St. Louis Encephalitis (SLE, MSI-7) Monoclonal Antibody, Unconjugated, Clone 1b5d-1 from CHEMICON
Normal Hamster Serum from Equitech-Bio
UV LAMP 254 NM 8 WATT from GE Healthcare, formerly Amersham Biosciences
Mouse Anti-PEPTIDOGLYCAN Monoclonal Antibody, Unconjugated, Clone 10H6 from AbD Serotec
Biology Products: